Larry A. Allen, MD, MHS, FAHA, FACC; Mats Börjesson, MD, PhD, FACC; Alan C. Braverman, MD, FACC; Julie A. Brothers, MD; Silvia Castelletti, MD, MSc, FESC; Eugene H ...

“Our study shows that modest, sustained changes in diet and lifestyle could prevent millions of cases of type 2 diabetes worldwide,” said coauthor Dr. Frank Hu, the Fredrick J. Stare Professor of ...

From Johns Hopkins University School of Medicine, Charlotte J. Sumner, M.D., presents an editorial on a study by Richard S. Finkel and colleagues, who report an open-label, Phase II trial of the ...

NEW YORK, NY / ACCESS Newswire / August 21, 2025 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a biopharmaceutical company developing novel neuro-active peptide therapies, today announced completion ...

1 Department of Physical Education, Xiamen University of Technology, Xiamen, China 2 Department of Physical Education, Changzhi Medical College, Changzhi, China Cardiovascular diseases (CVDs) are the ...

Alpha1H demonstrated significant efficacy in NMIBC, with 80% tumor response and 59% average tumor size reduction in the high-dose group. The drug induces rapid tumor cell apoptosis and immune ...

SHREVEPORT, La. (KSLA) - Phase 2 of construction of the new state building is underway in downtown Shreveport. According to the Downtown Development Authority (DDA), Phase 2 is the final stage. The ...

Viking Therapeutics has reported phase 2 data on its oral obesity drug candidate, linking the peptide to weight loss of up to 12.2% after 13 weeks. But, with 38% of patients discontinuing treatment at ...

In this document, the Inter-American Committee of Cardiovascular Prevention and Rehabilitation, together with the South American Society of Cardiology, aimed to formulate strategies, measures, and ...

Jesse Zanger is the managing editor of CBSNewYork.com. Jesse has previously worked for the Fox News Channel and Spectrum News NY1. He covers regional news around the Tri-State Area, with a particular ...